IGM Biosciences, Inc. (DELISTED) (IGMS:DL)
1.27
0.00 (0.00%)
USD |
NASDAQ |
Aug 22, 16:00
IGM Biosciences Profit Margin (Quarterly): 67.94% for June 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -23.49% |
| Tango Therapeutics, Inc. | 29.52% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.02% |
| Return on Assets | -21.87% |
| Return on Invested Capital | -50.80% |
| Gross Profit Margin (Quarterly) | 99.69% |
| Operating Margin (Quarterly) | 90.72% |
| Return on Net Operating Assets | -103.1% |